Cellular senescence as a target in cancer control

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Vergel, Mar ^a   Marin, Juan J ^b   Estevez, Purificacion ^a   Carnero, Amancio ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; APHIDICOLIN; BROXURIDINE; CHECKPOINT KINASE 2; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MITOCHONDRIAL DNA; PACLITAXEL; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE INHIBITOR; VINCRISTINE;

BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RESISTANCE; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL DEATH; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CODON; DNA METHYLATION; GROWTH INHIBITION; HETEROCHROMATIN; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SENESCENCE; SOMATIC MUTATION; SURVIVAL TIME; TELOMERE SHORTENING; TUMOR GROWTH;

EID: 84860991545     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/725365     Document Type: Review

References (122)

1. Hayflick L., The limited in vitro lifetime of human diploid cell strains. Experimental Cell Research 1965 37 3 614 636 2-s2.0-50549218525
2. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 (Pubitemid 30046295)
3. Untergasser G., Koch H. B., Menssen A., Hermeking H., Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Research 2002 62 21 6255 6262 2-s2.0-0036829854 (Pubitemid 35244479)
4. Mason D. X., Jackson T. J., Lin A. W., Molecular signature of oncogenic ras-induced senescence. Oncogene 2004 23 57 9238 9246 2-s2.0-11244334166 10.1038/sj.onc.1208172 (Pubitemid 40069694)
5. Schwarze S. R., Fu V. X., Desotelle J. A., Kenowski M. L., Jarrard D. F., The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 2005 7 9 816 823 2-s2.0-33644876537 10.1593/neo.05250
6. Shay J. W., Roninson I. B., Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004 23 16 2919 2933 2-s2.0-2342570379 10.1038/sj.onc.1207518 (Pubitemid 38638853)
7. Thomas E., Al-Baker E., Dropcova S., Denyer S., Ostad N., Lloyd A., Kill I. R., Faragher R. G. A., Different kinetics of senescence in human fibroblasts and peritoneal mesothelial cells. Experimental Cell Research 1997 236 1 355 358 2-s2.0-0031563829 10.1006/excr.1997.3760 (Pubitemid 27452382)
8. Rubin H., The disparity between human cell senescence in vitro and lifelong replication in vivo. Nature Biotechnology 2002 20 7 675 681 2-s2.0-0035989630 10.1038/nbt0702-675 (Pubitemid 34734133)
9. Wright W. F., Shay J. W., Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends in Cell Biology 1995 5 8 293 296 2-s2.0-0028981143 10.1016/S0962-8924(00)89044-3
10. Kipling D., Wynford-Thomas D., Jones C. J., Akbar A., Aspinall R., Bacchetti S., Blasco M. A., Broccoli D., DePinho R. A., Edwards D. R., Effros R. B., Harley C. B., Lansdorp P. M., Linskens M. H. K., Prowse K. R., Newbold R. F., Olovnikov A. M., Parkinson E. K., Pawelec G., Ponten J., Shall S., Zilmans M., Faragher R. G. A., Rubin H., Telomere-dependent senescence. Nature Biotechnology 1999 17 4 313 314 2-s2.0-0032892178
11. Olovnikov A. M., A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. Journal of Theoretical Biology 1973 41 1 181 190 2-s2.0-0015844590
12. Ruiz L., Traskine M., Ferrer I., Castro E., Leal J. F. M., Kaufman M., Carnero A., Characterization of the p53 response to oncogene-induced senescene. PLoS One 2008 3 9 2-s2.0-52449135085 10.1371/journal.pone.0003230 e3230
13. D'Adda Di Fagagna F., Living on a break: cellular senescence as a DNA-damage response. Nature Reviews Cancer 2008 8 7 512 522 2-s2.0-45849099050 10.1038/nrc2440 (Pubitemid 351881854)
14. Narita M., Nũnez S., Heard E., Narita M., Lin A. W., Hearn S. A., Spector D. L., Hannon G. J., Lowe S. W., Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003 113 6 703 716 2-s2.0-0037667702 10.1016/S0092-8674(03)00401-X (Pubitemid 36724935)
15. Campisi J., Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005 120 4 513 522 2-s2.0-13944270339 10.1016/j.cell.2005.02.003 (Pubitemid 40269765)
16. Castro P., Giri D., Lamb D., Ittmann M., Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 2003 55 1 30 38 2-s2.0-0037382970 10.1002/pros.10204 (Pubitemid 36397742)
17. Michaloglou C., Vredeveld L. C. W., Mooi W. J., Peeper D. S., BRAF in benign and malignant human tumours. Oncogene 2008 27 7 877 895 2-s2.0-38949131824 10.1038/sj.onc.1210704 (Pubitemid 351225383)
18. Krtolica A., Parrinello S., Lockett S., Desprez P. Y., Campisi J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proceedings of the National Academy of Sciences of the United States of America 2001 98 21 12072 12077 2-s2.0-0035834121 10.1073/pnas.211053698 (Pubitemid 32959828)
19. Bavik C., Coleman I., Dean J. P., Knudsen B., Plymate S., Nelson P. S., The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Research 2006 66 2 794 802 2-s2.0-31544479046 10.1158/0008-5472.CAN-05-1716 (Pubitemid 43165944)
20. Parrinello S., Coppe J. P., Krtolica A., Campisi J., Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. Journal of Cell Science 2005 118 3 485 496 2-s2.0-13944260728 10.1242/jcs.01635 (Pubitemid 40310116)
21. Coppé J. P., Patil C. K., Rodier F., Krtolica A., Beauséjour C. M., Parrinello S., Hodgson J. G., Chin K., Desprez P. Y., Campisi J., A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One 2010 5 2 2-s2.0-77949458344 10.1371/journal.pone.0009188 e9188
22. Coppé J. P., Patil C. K., Rodier F., Sun YU., Muñoz D. P., Goldstein J., Nelson P. S., Desprez P. Y., Campisi J., Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology 2008 6 12 2853 2868 2-s2.0-58149163445 10.1371/journal.pbio.0060301
23. Coppé J. P., Desprez P. Y., Krtolica A., Campisi J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology 2010 5 99 118 2-s2.0-77949881221 10.1146/annurev- pathol-121808-102144
24. Davalos A. R., Coppe J. P., Campisi J., Desprez P. Y., Senescent cells as a source of inflammatory factors for tumor progression. Cancer and Metastasis Reviews 2010 29 273 283 2-s2.0-77950586608 10.1007/s10555-010-9220-9
25. Collado M., Serrano M., The power and the promise of oncogene-induced senescence markers. Nature Reviews Cancer 2006 6 6 472 476 2-s2.0-33745712849 10.1038/nrc1884
26. Carnero A., Link W., Martinez J. F., Cellular senescence and cancer. Advances in Cancer Research 2003 3 183 198
27. Chandeck C., Mooi W. J., Oncogene-induced cellular senescence. Advances in Anatomic Pathology 2010 17 1 42 48 2-s2.0-75449097024 10.1097/PAP. 0b013e3181c66f4e
28. Braig M., Schmitt C. A., Oncogene-induced senescence: putting the brakes on tumor development. Cancer Research 2006 66 6 2881 2884 2-s2.0-33645526114 10.1158/0008-5472.CAN-05-4006
29. Courtois-Cox S., Jones S. L., Cichowski K., Many roads lead to oncogene-induced senescence. Oncogene 2008 27 20 2801 2809 2-s2.0-42949129074 10.1038/sj.onc.1210950 (Pubitemid 351620451)
30. Bartek J., Bartkova J., Lukas J., DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007 26 56 7773 7779 2-s2.0-36949005417 10.1038/sj.onc.1210881 (Pubitemid 350242463)
31. Ruzankina Y., Asare A., Brown E. J., Replicative stress, stem cells and aging. Mechanisms of Ageing and Development 2008 129 7-8 460 466 2-s2.0-45449106783 10.1016/j.mad.2008.03.009
32. Kenyon J., Gerson S. L., The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Research 2007 35 22 7557 7565 2-s2.0-38049024575 10.1093/nar/gkm1064
33. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garré M., Giovanni Nuciforo P., Bensimon A., Maestro R., Giuseppe Pelicci P., D'Adda Di Fagagna F., Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006 444 7119 638 642 2-s2.0-33845269825 10.1038/nature05327 (Pubitemid 44864443)
34. Passos J. F., Von Zglinicki T., Oxygen free radicals in cell senescence: are they signal transducers? Free Radical Research 2006 40 12 1277 1283 2-s2.0-33750703909 10.1080/10715760600917151 (Pubitemid 44698277)
35. Parrinello S., Samper E., Krtolica A., Goldstein J., Melov S., Campisi J., Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nature Cell Biology 2003 5 8 741 747 2-s2.0-0042195820 10.1038/ncb1024 (Pubitemid 36986782)
36. Vergel M., Carnero A., acarnero@ibis-sevilla.es Bypassing cellular senescence by genetic screening tools. Clinical and Translational Oncology 2010 12 6 410 417 10.1007/s12094-010-0528-2
37. Malumbres M., Carnero A., Cell cycle deregulation: a common motif in cancer. Progress in Cell Cycle Research 2003 5 5 18 2-s2.0-0642378446
38. Smith J. R., Pereira-Smith O. M., Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996 273 5271 63 67 2-s2.0-0030038104 (Pubitemid 26255421)
39. Duncan E. L., Whitaker N. J., Moy E. L., Reddel R. R., Assignment of SV40-immortalized cells to more than one complementation group for immortalization. Experimental Cell Research 1993 205 2 337 344 2-s2.0-0027271936 10.1006/excr.1993.1095 (Pubitemid 23192140)
40. Barrett J. C., Annab L. A., Alcorta D., Preston G., Vojta P., Yin Y., Cellular senescence and cancer. Cold Spring Harbor Symposia on Quantitative Biology 1994 59 411 418 2-s2.0-0028672688
41. Serrano M., Blasco M. A., Putting the stress on senescence. Current Opinion in Cell Biology 2001 13 6 748 753 2-s2.0-0035545802 10.1016/S0955- 0674(00)00278-7 (Pubitemid 33042736)
42. Schmitt C. A., Cellular senescence and cancer treatment. Biochimica et Biophysica Acta 2007 1775 1 5 20 2-s2.0-33845338765 10.1016/j.bbcan.2006.08.005 (Pubitemid 44881196)
43. Mooi W. J., Peeper D. S., Oncogene-induced cell senescence-halting on the road to cancer. New England Journal of Medicine 2006 355 10 1037 1046 2-s2.0-33748422079 10.1056/NEJMra062285 (Pubitemid 44343547)
44. Carnero A., Lleonart M. E., Epigenetic mechanisms in senescence, immortalisation and cancer. Biological Reviews of the Cambridge Philosophical Society. In press
45. Castro M. E., Ferrer I., Cascón A., Guijarro M. V., Lleonart M., y Cajal S. R., Leal J. F. M., Robledo M., Carnero A., PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 2008 29 3 491 499 2-s2.0-40949129547 10.1093/carcin/bgm246 (Pubitemid 351404864)
46. Leal J. F., Ferrer I., Blanco-Aparicio C., Hernández-Losa J., Ramón y Cajal S., Carnero A., Lleonart M. E., S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis 2008 29 11 2089 2095 2-s2.0-56049114215 10.1093/carcin/bgn198
47. LLeonart M. E., Vidal F., Gallardo D., Diaz-Fuertes M., Rojo F., Cuatrecasas M., López-Vicente L., Kondoh H., Blanco C., Carnero A., Cajal S. R., New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncology Reports 2006 16 3 603 608 2-s2.0-33749187263
48. Leal J. F. M., Fominaya J., Cascón A., Guijarro M. V., Blanco-Aparicio C., Lleonart M., Castro M. E., Ramon Y Cajal S., Robledo M., Beach D. H., Carnero A., Cellular senescence bypass screen identifies new putative tumor suppressor genes. Oncogene 2008 27 14 1961 1970 2-s2.0-41149095149 10.1038/sj.onc.1210846 (Pubitemid 351442744)
49. Kondoh H., Lleonart M. E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D., Glycolytic enzymes can modulate cellular life span. Cancer Research 2005 65 1 177 185 2-s2.0-11244347171 (Pubitemid 40070808)
50. Fridman A. L., Rosati R., Li Q., Tainsky M. A., Epigenetic and functional analysis of IGFBP3 and IGFBPrP1 in cellular immortalization. Biochemical and Biophysical Research Communications 2007 357 3 785 791 2-s2.0-34247521778 10.1016/j.bbrc.2007.04.019 (Pubitemid 46653848)
51. Kortlever R. M., Bernards R., Senescence, wound healing and cancer: the PAI-1 connection. Cell Cycle 2006 5 23 2697 2703 2-s2.0-33845418951 (Pubitemid 44901726)
52. Kortlever R. M., Higgins P. J., Bernards R., Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nature Cell Biology 2006 8 8 877 884 2-s2.0-33746616991 10.1038/ncb1448 (Pubitemid 44151592)
53. Wang W., Chen J. X., Liao R., Deng Q., Zhou J. J., Huang S., Sun P., Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Molecular and Cellular Biology 2002 22 10 3389 3403 2-s2.0-0036242247 10.1128/MCB.22.10.3389-3403.2002 (Pubitemid 34453979)
54. Haq R., Brenton J. D., Takahashi M., Finan D., Rottapel R., Zanke B., Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Research 2002 62 17 5076 5082 (Pubitemid 34987550)
55. Zhang H., Cohen S. N., Smurf2 up-regulation activates telomere-dependent senescence. Genes and Development 2004 18 24 3028 3040 2-s2.0-10644263286 10.1101/gad.1253004 (Pubitemid 39658172)
56. Shibanuma M., Mochizuki E., Maniwa R., Mashimo J. I., Nishiya N., Imai S. I., Takano T., Oshimura M., Nose K., Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Molecular and Cellular Biology 1997 17 3 1224 1235 2-s2.0-0031027206 (Pubitemid 27097351)
57. Campisi J., D'Adda Di Fagagna F., Cellular senescence: when bad things happen to good cells. Nature Reviews Molecular Cell Biology 2007 8 9 729 740 2-s2.0-34548186667 10.1038/nrm2233 (Pubitemid 47312822)
58. Wynford-Thomas D., p53: guardian of cellular senescence. Journal of Pathology 1996 180 2 118 121 2-s2.0-0029801598 10.1002/(SICI)1096-9896(199610) 180:2118::AID-PATH673>3.0.CO;2-I (Pubitemid 26370174)
59. Bond J., Haughton M., Blaydes J., Gire V., Wynford-Thomas D., Wyllie F., Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 1996 13 10 2097 2104 2-s2.0-0029841549 (Pubitemid 26411559)
60. Chin L., Artandi S. E., Shen Q., Tam A., Lee S. L., Gottlieb G. J., Greider C. W., DePinho R. A., p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999 97 4 527 538 2-s2.0-0033553516 10.1016/S0092-8674(00) 80762-X (Pubitemid 29231175)
61. Ashcroft M., Taya Y., Vousden K. H., Stress signals utilize multiple pathways to stabilize p53. Molecular and Cellular Biology 2000 20 9 3224 3233 2-s2.0-0034003005 10.1128/MCB.20.9.3224-3233.2000 (Pubitemid 30215034)
62. Blaydes J. P., Wynford-Thomas D., The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2. Oncogene 1998 16 25 3317 3322 2-s2.0-0032566066 (Pubitemid 28330431)
63. Kamijo T., Zindy F., Roussel M. F., Quelle D. E., Downing J. R., Ashmun R. A., Grosveld G., Sherr C. J., Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19(ARF). Cell 1997 91 5 649 659 2-s2.0-0030728468 (Pubitemid 27513656)
64. Carnero A., Hudson J. D., Price C. M., Beach D. H., p16(INK4A) and p19(ARF) act in overlapping pathways in cellular immortalization. Nature Cell Biology 2000 2 3 148 155 2-s2.0-0033622003 10.1038/35004020
65. Carnero A., Beach D. H., Absence of p21 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene 2004 23 35 6006 6011 2-s2.0-4043171390 10.1038/sj.onc.1207839 (Pubitemid 39093546)
66. Pantoja C., Serrano M., Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999 18 35 4974 4982 2-s2.0-0033517357 10.1038/sj.onc.1202880 (Pubitemid 29425304)
67. Brown J. P., Wei W., Sedivy J. M., Bypass of senescenoe after disruption of p21(CIP1)/(WAF1) gene in normal diploid human fibroblasts. Science 1997 277 5327 831 834 2-s2.0-0030609861 10.1126/science.277.5327.831 (Pubitemid 27366737)
68. Ho J. S. L., Ma W., Mao D. Y. L., Benchimol S., p53-dependent transcriptional repression of c-myc is required for G cell cycle arrest. Molecular and Cellular Biology 2005 25 17 7423 7431 2-s2.0-23844476499 10.1128/MCB.25.17.7423-7431.2005 (Pubitemid 41170106)
69. Jarrard D. F., Sarkar S., Shi Y., Yeager T. R., Magrane G., Kinoshita H., Nassif N., Meisner L., Newton M. A., Waldman F. M., Reznikoff C. A., p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Research 1999 59 12 2957 2964 2-s2.0-0033564106 (Pubitemid 29283138)
70. Haferkamp S., Tran S. L., Becker T. M., Scurr L. L., Kefford R. F., Rizos H., The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging 2009 1 6 542 556 2-s2.0-77952779168
71. Ye X., Zerlanko B., Zhang R., Somaiah N., Lipinski M., Salomoni P., Adams P. D., Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Molecular and Cellular Biology 2007 27 7 2452 2465 2-s2.0-34147143631 10.1128/MCB.01592-06 (Pubitemid 46581338)
72. Mulligan G., Jacks T., The retinoblastoma gene family: cousins with overlapping interests. Trends in Genetics 1998 14 6 223 229 2-s2.0-0031831681 10.1016/S0168-9525(98)01470-X (Pubitemid 28266973)
73. Carnero A., Hannon G. J., The INK4 family of CDK inhibitors. Current Topics in Microbiology and Immunology 1997 227 43 56 2-s2.0-0031436242 (Pubitemid 28023061)
74. Palmero I., McConnell B., Parry D., Brookes S., Hara E., Bates S., Jat P., Peters G., Accumulation of p16(INK4a) in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 1997 15 5 495 503 2-s2.0-0030612753 (Pubitemid 27384727)
75. Okamoto A., Demetrick D. J., Spillare E. A., Hagiwara K., Hussain S. P., Bennett W. P., Forrester K., Gerwin B., Greenblatt M. S., Serrano M., Shiseki M., Yokota J., Beach D. H., Harris C. C., p16(INK4)mutations and altered expression in human tumors and cell lines. Cold Spring Harbor Symposia on Quantitative Biology 1994 59 49 57 2-s2.0-0028671820
76. Krimpenfort P., Quon K. C., Mooi W. J., Loonstra A., Berns A., Loss of p16 confers susceptibility to metastatic melanoma in mice. Nature 2001 413 6851 83 86 2-s2.0-0035817687 10.1038/35092584 (Pubitemid 32843492)
77. Sharpless N. E., Bardeesy N., Lee K. H., Carrasco D., Castrillon D. H., Aguirre A. J., Wu E. A., Horner J. W., DePinho R. A., Loss of p16 with retention of p19 predisposes mice to tumorigenesis. Nature 2001 413 6851 86 91 2-s2.0-0035817688 10.1038/35092592 (Pubitemid 32843493)
78. Amati B., Alevizopoulos K., Vlach J., Myc and the cell cycle. Frontiers in Bioscience 1998 3 d250 d268 2-s2.0-0001170364
79. Wang J., Xie L. Y., Allan S., Beach D., Hannon G. J., Myc activates telomerase. Genes and Development 1998 12 12 1769 1774 2-s2.0-2642610318 (Pubitemid 28304329)
80. Gil J., Kerai P., Lleonart M., Bernard D., Cigudosa J. C., Peters G., Carnero A., Beach D., Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Research 2005 65 6 2179 2185 2-s2.0-16844371813 10.1158/0008-5472.CAN-03-4030 (Pubitemid 40490125)
81. Baylin S. B., Belinsky S. A., Herman J. G., Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise. Journal of the National Cancer Institute 2000 92 18 1460 1461 2-s2.0-0034692453
82. Brummelkamp T. R., Berns K., Hijmans E. M., Mullenders J., Fabius A., Heimerikx M., Velds A., Kerkhoven R. M., Madiredjo M., Bernards R., Beijersbergen R. L., Functional identification of cancer-relevant genes through large-scale RNA interference screens in mammalian cells. Cold Spring Harbor Symposia on Quantitative Biology 2004 69 439 445 2-s2.0-23044487333 10.1101/sqb.2004.69.439 (Pubitemid 41056584)
83. Michaloglou C., Vredeveld L. C. W., Soengas M. S., Denoyelle C., Kuilman T., Van Der Horst C. M. A. M., Majoor D. M., Shay J. W., Mooi W. J., Peeper D. S., BRAF-associated senescence-like cell cycle arrest of human naevi. Nature 2005 436 7051 720 724 2-s2.0-23244447037 10.1038/nature03890 (Pubitemid 41117276)
84. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A. J., Barradas M., Benguría A., Zaballos A., Flores J. M., Barbacid M., Beach D., Serrano M., Tumour biology: senescence in premalignant tumours. Nature 2005 436 7051 642 2-s2.0-23244447893 10.1038/436642a (Pubitemid 41117258)
85. Denchi E. L., Attwooll C., Pasini D., Helin K., Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Molecular and Cellular Biology 2005 25 7 2660 2672 2-s2.0-15044351968 10.1128/MCB.25.7.2660-2672.2005 (Pubitemid 40381630)
86. Chen Z., Trotman L. C., Shaffer D., Lin H. K., Dotan Z. A., Niki M., Koutcher J. A., Scher H. I., Ludwig T., Gerald W., Cordon-Cardo C., Pandolfi P. P., Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005 436 7051 725 730 2-s2.0-23244460597 10.1038/nature03918 (Pubitemid 41117277)
87. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A. H. F. M., Schlegelberger B., Stein H., Dörken B., Jenuwein T., Schmitt C. A., Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005 436 7051 660 665 2-s2.0-23244461708 10.1038/nature03841 (Pubitemid 41117262)
88. Roninson I. B., Tumor cell senescence in cancer treatment. Cancer Research 2003 63 11 2705 2715 2-s2.0-0038277105 (Pubitemid 36667137)
89. Pereira-Smith O. M., Smith J. R., Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proceedings of the National Academy of Sciences of the United States of America 1988 85 16 6042 6046 2-s2.0-0011208723
90. McConnell B. B., Starborg M., Brookes S., Peters G., Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Current Biology 1998 8 6 351 354 2-s2.0-0032510327 (Pubitemid 28159123)
91. Carnero A., Hudson J. D., Hannon G. J., Beach D. H., Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Research 2000 28 11 2234 2241 2-s2.0-0034209908 (Pubitemid 30639356)
92. Carnero A., Targeting the cell cycle for cancer therapy. British Journal of Cancer 2002 87 2 129 133 2-s2.0-0037100740 10.1038/sj.bjc.6600458
93. Ball K. L., Lain S., Fåhraeus R., Smythe C., Lane D. P., Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21(WAF1). Current Biology 1997 7 1 71 80 2-s2.0-0031025385 (Pubitemid 27058942)
94. Schmitt C. A., Fridman J. S., Yang M., Lee S., Baranov E., Hoffman R. M., Lowe S. W., A senescence program controlled by p53 and p16 contributes to the outcome of cancer therapy. Cell 2002 109 3 335 346 2-s2.0-0037013154 10.1016/S0092-8674(02)00734-1 (Pubitemid 34606876)
95. Lowe S. W., Ruley H. E., Jacks T., Housman D. E., p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993 74 6 957 967 2-s2.0-0027451668 10.1016/0092-8674(93)90719-7 (Pubitemid 23289454)
96. Lowe S. W., Cepero E., Evan G., Intrinsic tumour suppression. Nature 2004 432 7015 307 315 2-s2.0-9244224723 10.1038/nature03098 (Pubitemid 39551658)
97. Roninson I. B., Tumor senescence as a determinant of drug response in vivo. Drug Resistance Updates 2002 5 5 204 208 2-s2.0-0036815596 10.1016/S1368764602001103 (Pubitemid 35429450)
98. te Poele R. H., Okorokov A. L., Jardine L., Cummings J., Joel S. P., DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Research 2002 62 6 1876 1883 2-s2.0-0037086268 (Pubitemid 34408516)
99. Maloney K. W., McGavran L., Odom L. F., Hunger S. P., Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia. Blood 1999 93 7 2380 2385 2-s2.0-0033121072 (Pubitemid 29153642)
100. Carter T. L., Watt P. M., Kumar R., Burton P. R., Reaman G. H., Sather H. N., Baker D. L., Kees U. R., Hemizygous p16 deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood 2001 97 2 572 574 2-s2.0-0035863837 10.1182/blood.V97.2.572 (Pubitemid 32060347)
101. Elenitoba-Johnson K. S. J., Gascoyne R. D., Lim M. S., Chhanabai M., Jaffe E. S., Raffeld M., Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998 91 12 4677 4685 2-s2.0-0031839956 (Pubitemid 28270317)
102. Chen Q. M., Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints. Annals of the New York Academy of Sciences 2000 908 111 125 2-s2.0-0033913425 (Pubitemid 30461997)
103. Chang B.-D., Broude E. V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E. S., Lausch E., Christov K., Roninson I. B., roninson@uic.edu A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Research 1999 59 15 3761 3767 (Pubitemid 29381884)
104. Wang X., Wong S. C. H., Pan J., Tsao S. W., Fung K. H. Y., Kwong D. L. W., Sham J. S. T., Nicholls J. M., Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Research 1998 58 22 5019 5022 2-s2.0-0032533504 (Pubitemid 28521151)
105. Yeo E. J., Hwang Y. C., Kang C. M., Kim I. H., Kim D. I., Parka J. S., Choy H. E., Park W. Y., Park S. C., Senescence-like changes induced by hydroxyurea in human diploid fibroblasts. Experimental Gerontology 2000 35 5 553 571 2-s2.0-0034253576 10.1016/S0531-5565(00)00108-X
106. Michishita E., Nakabayashi K., Suzuki T., Kaul S. C., Ogino H., Fujii M., Mitsui Y., Ayusawa D., 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. Journal of Biochemistry 1999 126 6 1052 1059 2-s2.0-0033381225 (Pubitemid 30014451)
107. Chang B. D., Xuan Y., Broude E. V., Zhu H., Schott B., Fang J., Roninson I. B., Role of p53 and p21(waf1/cip1) in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999 18 34 4808 4818 2-s2.0-0033606852 10.1038/sj.onc.1203078 (Pubitemid 29423564)
108. Elmore L. W., Rehder C. W., Di X., McChesney P. A., Jackson-Cook C. K., Gewirtz D. A., Holt S. E., Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. Journal of Biological Chemistry 2002 277 38 35509 35515 2-s2.0-0037144595 10.1074/jbc.M205477200
109. Gire V., Roux P., Wynford-Thomas D., Brondello J. M., Dulic V., DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO Journal 2004 23 13 2554 2563 2-s2.0-3342929538 10.1038/sj.emboj.7600259 (Pubitemid 38988227)
110. Moiseeva O., Mallette F. A., Mukhopadhyay U. K., Moores A., Ferbeyre G., g.ferbeyre@umontreal.ca DNA damage signaling and p53-dependent senescence after prolonged β -interferon stimulation. Molecular Biology of the Cell 2006 17 4 1583 1592 10.1091/mbc.E05-09-0858 (Pubitemid 44011578)
111. Wells S. I., Francis D. A., Karpova A. Y., Dowhanick J. J., Benson J. D., Howley P. M., Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO Journal 2000 19 21 5762 5771 2-s2.0-0034331178
112. Lodygin D., Menssen A., Hermeking H., Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation 2002 110 11 1717 1727 2-s2.0-0036897350 10.1172/JCI200216588 (Pubitemid 35424250)
113. Roninson I. B., Dokmanovic M., Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids. Journal of Cellular Biochemistry 2003 88 1 83 94 2-s2.0-0037214472 10.1002/jcb.10320 (Pubitemid 36015077)
114. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W., Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266 5193 2011 2015 2-s2.0-0028564951
115. Hahn W. C., Stewart S. A., Brooks M. W., York S. G., Eaton E., Kurachi A., Beijersbergen R. L., Knoll J. H. M., Meyerson M., Weinberg R. A., Inhibition of telomerase limits the growth of human cancer cells. Nature Medicine 1999 5 10 1164 1170 2-s2.0-0032828652 10.1038/13495 (Pubitemid 29474421)
116. Blasco M. A., Lee H. W., Hande M. P., Samper E., Lansdorp P. M., DePinho R. A., Greider C. W., Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997 91 1 25 34 2-s2.0-0030931491 10.1016/S0092-8674(01)80006-4 (Pubitemid 27431310)
117. Rudolph K. L., Chang S., Lee H. W., Blasco M., Gottlieb G. J., Greider C., DePinho R. A., Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999 96 5 701 712 2-s2.0-0033525558 (Pubitemid 29122812)
118. Vulliamy T. J., t.vulliamy@imperial.ac.uk Marrone A., Knight S. W., Walne A., Mason P. J., Dokal I., Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006 107 7 2680 2685 10.1182/blood-2005-07-2622
119. Marciniak R., Guarente L., Human genetics: testing telomerase. Nature 2001 413 6854 370 373 2-s2.0-0035959968 10.1038/35096663 (Pubitemid 32928577)
120. Artandi S. E., DePinho R. A., Mice without telomerase: what can they teach us about human cancer? Nature Medicine 2000 6 8 852 855 2-s2.0-0033835452 10.1038/78595 (Pubitemid 30644736)
121. Holt S. E., Wright W. E., Shay J. W., Multiple pathways for the regulation of telomerase activity. European Journal of Cancer A 1997 33 5 761 766 2-s2.0-0030988271 10.1016/S0959-8049(97)00066-X (Pubitemid 27239486)
122. Zhang X., Mar V., Zhou W., Harrington L., Robinson M. O., Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes and Development 1999 13 18 2388 2399 2-s2.0-0033568462 10.1101/gad.13.18.2388 (Pubitemid 29453610)